Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-07-15
著者
-
Widmer N.
Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
-
Rochat B.
Plate-forme De Spectrometrie De Masse Department De Recherche Centre Hospitalier Universitaire Vaudo
-
Leyvraz S.
Pluridisciplinary Cancer Center Centre Hospitalier Universitaire Vaudois
-
Duchosal M.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Zaman K.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Rochat B.
Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univ
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Leyvraz S.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
HAOUALA A.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
ZANOLARI B.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
MONTEMURRO M.
Multidisciplinary Oncology Centre, Centre Hospitalier Universitaire Vaudois and University of Lausan
-
RIS H.
Divisions of Thoracic and Vascular Surgery, Centre Hospitalier Universitaire Vaudois and University
-
Ris H.
Divisions Of Thoracic And Vascular Surgery Centre Hospitalier Universitaire Vaudois And University O
-
Haouala A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Montemurro M.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Zanolari B.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Widmer N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Zanolari B.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
関連論文
- Determination of imatinib (Gleevec^【○!R】) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection
- Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
- Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples
- Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction
- Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction
- High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements
- Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
- A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents : Raltegravir, maraviroc, darunavir, and etravirine
- An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma : First evidence of 4'-hydroxylated metabolites in breast cancer patients
- A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma